Year
2023
-
AstraZeneca and Ionis’ ATTRv-PN therapy meets trial endpoints
-
Avidity Biosciences Inc. Granted FDA Fast Track Designation for Antibody AOC 1044
-
Trefoil Therapeutics reports new findings from FECD therapy trial
-
Janssen Gets EU Approval for Prostate Cancer Drug Akeega
-
CHMP recommends approval for GSK’s RSV vaccine candidate
-
National Institute for Health and Care Excellence approves expanded use of Yescarta and Tecartus
-
Danaher’s Aldevron unit plots mRNA manufacturing expansion
-
Teva, MedinCell win FDA approval for slow-release schizophrenia drug Uzedy
-
With FDA nod for Lumryz, Avadel is set to Jazz up the narcolepsy market
-
Alzheimer’s drug developed by Lilly slows cognitive decline by 35 pct